• Health & Medicine

One lung cancer drug receives NHS England approval, while another is rejected

A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer.

5 July 2019

• Health & Medicine

New skin cancer immunotherapy added to NHS England’s Cancer Drugs Fund

A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England. A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.

4 July 2019

• Health & Medicine

Obese people outnumber smokers two to one

People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types. People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types.

3 July 2019

• Policy & Insight

Opinion: 'New brain tumour research projects reflect Tessa Jowell’s legacy'

'The word ‘legacy’ is often overused, but not about the late Baroness Tessa Jowell'. Michelle Mitchell reflects on Cancer Research UK's new brain tumour funding. 'The word ‘legacy’ is often overused, but not about the late Baroness Tessa Jowell'. Michelle Mitchell reflects on Cancer Research UK's new brain tumour funding.

20 June 2019

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Science & Technology

The scientists on a mission to revolutionise brain tumour research

Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research. Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.

17 June 2019

• For Supporters

Glioblastoma and children’s brain tumours: teams awarded £18 million Cancer Research UK Brain Tumour Awards

Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop. Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.

17 June 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• Health & Medicine

Immunotherapy comparable to chemo for some advanced stomach cancers

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe. An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

1 June 2019

• Health & Medicine

Precision drug combo boosts survival in younger women with advanced breast cancer

Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial. Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.

1 June 2019